On September 13th, journalist Vivienne Parry interviewed InMed Pharmaceuticals’ President and CEO, Eric A. Adams, and BayMedica’s co-founder, Shane Johnson. In their first interview together, Eric and Shane talked about the acquisition and their shared vision of the combined company.
What quality controls should be put in place to ensure consistency and purity of cannabinoids for CPG products?
Dr. Shane Johnson, GM of BayMedica, InMed’s subsidiary, answers these questions: What is the minimum GMP standard that consumers should expect? What quality controls should